DE3871798D1 - Modifizierter faktor vii/viia. - Google Patents

Modifizierter faktor vii/viia.

Info

Publication number
DE3871798D1
DE3871798D1 DE8888905735T DE3871798T DE3871798D1 DE 3871798 D1 DE3871798 D1 DE 3871798D1 DE 8888905735 T DE8888905735 T DE 8888905735T DE 3871798 T DE3871798 T DE 3871798T DE 3871798 D1 DE3871798 D1 DE 3871798D1
Authority
DE
Germany
Prior art keywords
viia
factor vii
modified factor
proteolytically
sensible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888905735T
Other languages
English (en)
Other versions
DE3871798T2 (de
Inventor
Marie Nicolaisen
Erik Bjorn
Finn Wiberg
Richard Woodbury
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk Health Care AG
Zymogenetics Inc
Original Assignee
Novo Nordisk AS
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS, Zymogenetics Inc filed Critical Novo Nordisk AS
Publication of DE3871798D1 publication Critical patent/DE3871798D1/de
Application granted granted Critical
Publication of DE3871798T2 publication Critical patent/DE3871798T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE8888905735T 1987-06-25 1988-06-24 Modifizierter faktor vii/viia. Expired - Lifetime DE3871798T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK323587A DK323587D0 (da) 1987-06-25 1987-06-25 Protein
PCT/DK1988/000103 WO1988010295A1 (en) 1987-06-25 1988-06-24 MODIFIED FACTOR VII/VIIa

Publications (2)

Publication Number Publication Date
DE3871798D1 true DE3871798D1 (de) 1992-07-09
DE3871798T2 DE3871798T2 (de) 1993-05-13

Family

ID=8120606

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888905735T Expired - Lifetime DE3871798T2 (de) 1987-06-25 1988-06-24 Modifizierter faktor vii/viia.

Country Status (7)

Country Link
EP (1) EP0370036B1 (de)
JP (1) JPH03500963A (de)
AT (1) ATE76900T1 (de)
CA (1) CA1339815C (de)
DE (1) DE3871798T2 (de)
DK (2) DK323587D0 (de)
WO (1) WO1988010295A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580560A (en) * 1989-11-13 1996-12-03 Novo Nordisk A/S Modified factor VII/VIIa
EP0506821B1 (de) * 1989-12-29 1998-02-04 Zymogenetics, Inc. Hybrides protein c
US5358932A (en) * 1989-12-29 1994-10-25 Zymogenetics, Inc. Hybrid protein C
ATE180834T1 (de) * 1990-01-29 1999-06-15 Zymogenetics Inc Antikoagulierende proteine
US6747003B1 (en) 1997-10-23 2004-06-08 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6693075B1 (en) 1997-10-23 2004-02-17 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US7247708B2 (en) 1997-10-23 2007-07-24 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
DK1257295T3 (da) 2000-02-11 2009-08-10 Bayer Healthcare Llc Faktor VII eller VIIA-lignende molekyler
US7220837B1 (en) 2000-04-28 2007-05-22 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US7812132B2 (en) 2000-04-28 2010-10-12 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6905683B2 (en) 2000-05-03 2005-06-14 Novo Nordisk Healthcare A/G Human coagulation factor VII variants
US20030211094A1 (en) 2001-06-26 2003-11-13 Nelsestuen Gary L. High molecular weight derivatives of vitamin k-dependent polypeptides
RU2326126C2 (ru) 2000-09-13 2008-06-10 Ново Нордиск Хелт Кэр Аг Полипептид фактора vii свертывания крови, его получение и применение
IL154520A0 (en) * 2000-09-13 2003-09-17 Novo Nordisk As Human coagulation factor vii variants
AU2002218029A1 (en) 2000-11-09 2002-05-21 The Scripps Research Institute Modified factor viia
MXPA03008590A (es) * 2001-03-22 2003-12-08 Novo Nordisk Healthcare Ag Derivados del factor vii de coagulacion.
US7052868B2 (en) 2001-09-27 2006-05-30 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
CN1602354A (zh) * 2001-09-27 2005-03-30 诺和诺德医疗保健公司 人凝血因子ⅶ多肽
JP2005512524A (ja) * 2001-11-02 2005-05-12 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト ヒト凝固第ｖｉｉ因子ポリペプチド
US6960657B2 (en) 2001-11-02 2005-11-01 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
RU2004134726A (ru) 2002-04-30 2005-06-10 Максиджен Холдингз Лтд. (Ky) Варианты полипептида фактора vii или viia
US6911323B2 (en) 2002-09-25 2005-06-28 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
ATE505487T1 (de) 2002-09-30 2011-04-15 Bayer Healthcare Llc Fvii- oder fviia-varianten mit erhöhter koagulationswirkung
CA2519873C (en) 2003-03-20 2012-12-18 Maxygen Holdings Ltd. Fvii or fviia variants
US8791070B2 (en) 2003-04-09 2014-07-29 Novo Nordisk A/S Glycopegylated factor IX
ES2338425T3 (es) 2003-06-19 2010-05-07 Bayer Healthcare Llc Variantes de dominio de gla del factor vii o viia.
ATE547519T1 (de) 2003-09-09 2012-03-15 Novo Nordisk Healthcare Ag Gerinnungsfaktor-vii-polypeptide
US20060040856A1 (en) 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
CN101006175A (zh) 2004-08-17 2007-07-25 Csl百灵有限公司 经修饰的维生素k依赖性多肽
EP2975135A1 (de) 2005-05-25 2016-01-20 Novo Nordisk A/S Glykopegylierter Faktor IX
KR20100016462A (ko) 2007-04-13 2010-02-12 카탈리스트 바이오사이언시즈, 인코포레이티드 변형 제ｖｉｉ 인자 폴리펩타이드 및 이의 용도
CA2690611C (en) 2007-06-12 2015-12-08 Novo Nordisk A/S Improved process for the production of nucleotide sugars
FR2917414B1 (fr) * 2007-06-15 2012-07-13 Lab Francais Du Fractionnement Facteur vii/viia humain modifie et composition pharmaceutique contenant celui-ci
TWI538916B (zh) 2008-04-11 2016-06-21 介控生化科技公司 經修飾的因子vii多肽和其用途
PL3266463T3 (pl) 2009-06-09 2024-03-18 Prolong Pharmaceuticals, LLC Kompozycje hemoglobiny
US20210069306A1 (en) 2019-08-15 2021-03-11 Catalyst Biosciences, Inc. Modified factor vii polypeptides for subcutaneous administration and on-demand treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2461040A1 (fr) * 1979-07-09 1981-01-30 Inst Textile De France Procede et dispositif pour l'obtention d'un fil presentant sur sa longueur des zones de torsion alternativement de sens inverse
US4753879A (en) * 1984-08-27 1988-06-28 Biogen N.V. Modified tissue plasminogen activators
EP0201153A3 (de) * 1985-02-09 1987-10-07 Beecham Group Plc Modifiziertes Enzym und Verfahren zu dessen Herstellung
GR860984B (en) * 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
DK43387A (da) * 1986-01-29 1987-07-30 Beecham Group Plc Fibrinolytisk enzym

Also Published As

Publication number Publication date
CA1339815C (en) 1998-04-14
DK653989A (da) 1989-12-21
WO1988010295A1 (en) 1988-12-29
JPH03500963A (ja) 1991-03-07
DK161097B (da) 1991-05-27
ATE76900T1 (de) 1992-06-15
DK161097C (da) 1991-11-11
EP0370036A1 (de) 1990-05-30
DK653989D0 (da) 1989-12-21
DK323587D0 (da) 1987-06-25
EP0370036B1 (de) 1992-06-03
DE3871798T2 (de) 1993-05-13

Similar Documents

Publication Publication Date Title
ATE76900T1 (de) Modifizierter faktor vii/viia.
DK105489D0 (da) Polypeptid
HUT54213A (en) Process for the enzymatic removal of n-terminal sequence of proteins
ES8802235A1 (es) Procedimiento para preparar un polipeptido
ATE142258T1 (de) Menschlicher gefässpermeabilitätsfaktor
DE3856265D1 (de) Varianten des pankreatischen Rinder-Trypsininhibitors, deren Herstellung und Verwendung
KR880701105A (ko) 신규 응혈촉진 단백질
ATE92107T1 (de) N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen.
ES8801674A1 (es) Un procedimiento para la preparacion de una proteina que presenta actividad procoagulante.
DE69129865D1 (de) Osteogene peptide
ES548617A0 (es) Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo
EP0423224A4 (en) Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor
ATE144535T1 (de) Plättchen blockierende peptide
DE59810198D1 (de) Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung
ATE146188T1 (de) Substituierungsanaloge von magaininpeptiden
NO893452D0 (no) Rekombinant naturlig dreper-celleaktivator.
BR9809416A (pt) Processo para clivagem de proteìnas de fusão
ZA896980B (en) Peptide compounds
ES2168282T3 (es) D-hidantoinasa recombinante, procedimiento para su preparacion y utilizacion.
DK262986A (da) Peptidmateriale med thymushumoral aktivitet
ATE124955T1 (de) Substrat-peptide.
FR2569111B1 (fr) Nouveaux medicaments contenant des tripeptides
AU637589B2 (en) Ancrod proteins, their production and use
DK0563385T3 (da) Thrombolytisk peptid, fremstilling deraf og thrombolytisk middel
DE59209915D1 (de) Verfahren zur Herstellung von Polypeptiden mit Prourokinase-Aktivität

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVO NORDISK HEALTH CARE AG, ZUERICH, CH

Owner name: ZYMOGENETICS, INC., SEATTLE, WASH., US